When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Neuroscience
Link
http://link.springer.com/article/10.1007/s11910-018-0825-7/fulltext.html
Reference73 articles.
1. Ostrom Q, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-Oncology. 2013;15(Suppl 2):56–ii56. https://doi.org/10.1093/neuonc/not151 .
2. Norden AD, Drappatz J, Wen PY. Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol. 2009;5(11):610–20. https://doi.org/10.1038/nrneurol.2009.159 .
3. Claes A, Idema A, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 2007;114(5):443–58. https://doi.org/10.1007/s00401-007-0293-7 .
4. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462–77. https://doi.org/10.1016/j.cell.2013.09.034 .
5. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013;110:6021–6. https://doi.org/10.1073/pnas.1303607110 .
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements in Telomerase-Targeted Therapies for Glioblastoma: A Systematic Review;International Journal of Molecular Sciences;2024-08-09
2. Genetic Prognostic Factors in Adult Diffuse Gliomas: A 10-Year Experience at a Single Institution;Cancers;2024-06-01
3. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas;Clinical Neuroradiology;2024-01-26
4. Nucleic acid immunotherapeutics and vaccines: A promising approach to glioblastoma multiforme treatment;International Journal of Pharmaceutics;2023-05
5. Telomerase inhibition in malignant gliomas: a systematic review;Expert Reviews in Molecular Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3